WO2022225593A1 - Use of high quality protein concentrate as an antibacterial for shellfish - Google Patents

Use of high quality protein concentrate as an antibacterial for shellfish Download PDF

Info

Publication number
WO2022225593A1
WO2022225593A1 PCT/US2022/015266 US2022015266W WO2022225593A1 WO 2022225593 A1 WO2022225593 A1 WO 2022225593A1 US 2022015266 W US2022015266 W US 2022015266W WO 2022225593 A1 WO2022225593 A1 WO 2022225593A1
Authority
WO
WIPO (PCT)
Prior art keywords
shrimp
prawn
hqpc
protein
feed
Prior art date
Application number
PCT/US2022/015266
Other languages
English (en)
French (fr)
Inventor
Sergio F. NATES
Original Assignee
Prairie Aquatech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prairie Aquatech Llc filed Critical Prairie Aquatech Llc
Priority to CN202280026501.XA priority Critical patent/CN117202791A/zh
Publication of WO2022225593A1 publication Critical patent/WO2022225593A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/16—Vegetable proteins from soybean
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/14—Vegetable proteins
    • A23J3/18—Vegetable proteins from wheat
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/22—Working-up of proteins for foodstuffs by texturising
    • A23J3/26—Working-up of proteins for foodstuffs by texturising using extrusion or expansion
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/22—Animal feeding-stuffs from material of animal origin from fish
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion

Definitions

  • the invention generally relates to plant-based protein concentrates, and specifically a high quality protein concentrate that has antimicrobial properties in shellfish, including methods of treating shellfish against Vibrio species infection.
  • AHPND Acute Hepatopancreatic Necrosis Syndrome
  • Early Mortality Syndrome is a destructive disease of farmed shrimp.
  • the disease has been associated with Vibrio parahaemolyticus which spread to the Western Hemisphere and emerged in Mexico in early 2013. Since the first reported case in southern China in 2009, AHPND has also been observed in shrimp farms in other areas in Asia and the Americas, and the outbreak has inflicted severe damage to the global shrimp farming industry with annual losses of more than $1 billion.
  • the present disclosure relates to an organic, microbially-enhanced protein based diet which inhibits/mitigates Vibrio infection in shrimp larvae, including methods of treating shrimp with diets containing said microbially-enhanced protein as a means to prevent/reduce Vibrio infection.
  • a feed composition including a fermented agricultural biomass, where the feed composition improves the resistance of shellfish to Vibrio species associated with Acute Hepatopancreatic Necrosis Syndrome (AHPND)/Early Mortality Syndrome (EMS) compared to the same feed composition lacking the fermented agricultural biomass.
  • AHPND Acute Hepatopancreatic Necrosis Syndrome
  • EMS Early Mortality Syndrome
  • the agricultural biomass is High Quality Protein Concentrate (HQPC) from an agricultural biomass selected from the group consisting of soybeans, sorghum, peanuts, pulses, Rapeseeds, oats, barley, rye, lupins, fava beans, canola, peas, sesame seeds, cottonseeds, palm kernels, barley, grape seeds, olives, safflowers, sunflowers, copra, corn, coconuts, linseed, hazelnuts, wheat, rice, potatoes, cassavas, legumes, camelina seeds, pennycress seeds, mustard seeds, wheat germ meal, corn gluten meal, corn gluten feed, distillery/brewery by-products, and combinations thereof, and where the fermented agricultural biomass exhibits the improved resistance property at an inclusion rate of between 1% and 10% (dmb).
  • HQPC High Quality Protein Concentrate
  • the agricultural biomass is fermented with an organism selected from the group consisting of Aureobasidium pullulans , Kluyveromyces spp., Pichia spp, lactic acid bacteria, Trichoderma reesei, Pleurotus ostreatus, Rhizopus spp. and combinations thereof via submerged fermentation.
  • an organism selected from the group consisting of Aureobasidium pullulans , Kluyveromyces spp., Pichia spp, lactic acid bacteria, Trichoderma reesei, Pleurotus ostreatus, Rhizopus spp. and combinations thereof via submerged fermentation.
  • the organism is a fungus.
  • the fungus is Aureobasidium pullulans.
  • the agricultural biomass is from soy.
  • the Vibrio species include V. alginolyticus, V. parahaemolyticus, V. harveyi, V. vulnificus , V. diabolicus , V. dam sella, V.fischeri , V. anguillarum , V. campbelli , F. pelagians, V. orientalis, V. ordalii , F. mediterrani, and F. logei.
  • the fermented agricultural biomass content of the composition is between about 1% and 10% of the dry weight of the feed composition.
  • the shellfish includes Kadal shrimp, endeavour shrimp, greasyback shrimp, speckled shrimp, northern brown shrimp, fleshy prawn, brown tiger prawn, Indian white prawn, Kuruma prawn, caramote prawn, banana prawn, giant tiger prawn, southern pink shrimp, Sao Paulo shrimp, redtail prawn, southern white shrimp, Green tiger prawn, Northern white shrimp, Blue shrimp, Southern brown shrimp, Whiteleg shrimp, Atlantic seabob, Akiami paste shrimp, Monsoon river prawn, giant river prawn, common prawn, American lobster, European lobster, noble crayfish, Danube crayfish, signal crayfish, red swamp crawfish, yabby crayfish, red claw crayfish, marron crayfish, longlegged spiny lobster, gazami crab, Indo-Pacific swamp crab, Chinese river crab, and combinations thereof.
  • the shellfish is shrimp, and where the shrimp is Litopenaeus vannamei.
  • a method of preventing, treating or providing a prophylactic against Acute Hepatopancreatic Necrosis Syndrome (AHPND)/Early Mortality Syndrome (EMS) caused by Vibrio species in shellfish including feeding shrimp larvae a feed composition comprising High Quality Protein Concentrate (HQPC) within 20-30 days after stocking an aquaculture pond or tank.
  • AHPND Acute Hepatopancreatic Necrosis Syndrome
  • EMS Early Mortality Syndrome
  • the HQPC content of the feed composition is between 1% and 10% of the dry weight of the feed composition, and where the shellfish are present at high stocking density or hyper-intensive stocking density.
  • the method further includes selecting samples from the feed shellfish, and isolating shrimp larvae macerates, where the macerates are evaluated for the presence of Vibrio species.
  • the macerates are evaluated by PCR via the detection of AP4 toxin or by determining bacterial reduction in shellfish larvae exhibiting disease signs related to AHPND/EMS.
  • the primers for PCR include sequences as set forth in SEQ ID NO:23 and SEQ ID NO:24.
  • the feed includes one or more of fishmeal, poultry byproduct meal, distiller’s dried grains with solubles, corn gluten meal, and soybean meal mixed with HQPC, where the HQPC includes a fermented plant product containing low-pullulan yielding A. pullulans and from at least about 65% to about 75% protein content (dmb), where the HQPC exhibits one or more of the properties including a degree of hydrolysis (DH) of at least about 2%, an ash content of up to about 4%, or a potassium and magnesium content of less than about 0.1 ppm.
  • DH degree of hydrolysis
  • the Vibrio species include V. alginolyticus , V. parahaemolyticus, V. harveyi , V. vulnificus , V. diabolicus , V. dam sella, V.fischeri , V. anguillarum , V. campbelli , V. pelagians, V. orientalis , V. ordalii , V. mediterrani, and V. logei.
  • the shellfish includes Kadal shrimp, endeavour shrimp, greasyback shrimp, speckled shrimp, northern brown shrimp, fleshy prawn, brown tiger prawn, Indian white prawn, Kuruma prawn, caramote prawn, banana prawn, giant tiger prawn, southern pink shrimp, Sao Paulo shrimp, redtail prawn, southern white shrimp, Green tiger prawn, Northern white shrimp, Blue shrimp, Southern brown shrimp, Whiteleg shrimp, Atlantic seabob, Akiami paste shrimp, Monsoon river prawn, giant river prawn, common prawn, American lobster, European lobster, noble crayfish, Danube crayfish, signal crayfish, red swamp crawfish, yabby crayfish, red claw crayfish, marron crayfish, longlegged spiny lobster, gazami crab, Indo-Pacific swamp crab, Chinese river crab, and combinations thereof.
  • Kadal shrimp endeavour shrimp, greasyback shrimp
  • an HQPC to produce a medicament feed to prevent, treat or provide a prophylactic against Acute Hepatopancreatic Necrosis Syndrome (AHPND)/Early Mortality Syndrome (EMS) in shellfish
  • the medicament feed includes one or more of fishmeal, poultry byproduct meal, distiller’s dried grains with solubles, corn gluten meal, and soybean meal mixed with HQPC
  • the HQPC comprises a fermented plant product obtained by submerged fermentation containing low-pullulan yielding A.
  • HQPC exhibits one or more of the properties including degree of hydrolysis (DH) of at least about 2%, an ash content of up to about 4%, or a potassium and magnesium content of less than about 0.1 ppm.
  • DH degree of hydrolysis
  • the HQPC exhibits a shift downward in a raw NIR spectra between 4664 cm 1 and 4836 cm 1 relative to the feed stock from which it is produced.
  • Figure 1 shows a flow chart for an HQSPC conversion process.
  • Figure 2 shows a flow chart for an HQSPC conversion process for aqua feeds.
  • Figure 3 shows bench scale, extended incubation trials to evaluate HQSPC composition and yield.
  • Figure 4 shows a flow chart for an HP-DDGS conversion process for aqua feeds.
  • Figure 5 shows the effect of moisture content and extrusion speed on glucose recovery following extrusion of HP-DDGS at 100°C.
  • Figure 6 shows an outline of a separate HQPC process as disclosed herein.
  • Figure 7 shows details for centrate 1.
  • Figure 8 shows details for centrate 4.
  • Figure 9 shows value added products for outline in Figure 6.
  • FIG. 10 shows raw spectra for different SBM feed stock samples.
  • the x-axis is wavenumber and the y-axis is intensity in absorbance units (AU).
  • FIG. 11 shows raw spectra for different HQPC products made from the SBM samples in FIG. 10.
  • the x-axis is wavenumber and the y-axis is intensity in AU.
  • FIG. 12 Final weight (g) of Rainbow trout fed diets containing HQPC (25%) vs. fish meal diets.
  • FIG. 13a Weekly growth rate (g) performance of Coho Salmon fed HQPC.
  • FIG. 13b Feed conversion rate (FCR) of Coho Salmon fed HQPC.
  • FIG. 14 Survival of first feeding L. vannamei larvae (Z3 -PL13) fed artificial feeds containing HQPC.
  • FIG. 15 Average Body Weight (g) of L. vannamei juveniles fed artificial feeds containing HQPC.
  • FIG. 16 Survival rate (%) of L. vannamei juveniles fed artificial feeds containing HQPC on day 10th of a post-challenge with EMS. Means sharing the same superscript are not significantly different from each other (Tukey’s HSD, P ⁇ 0.05).
  • FIG. 17 shows HQPC inhibitory activity on V. parahaemolyticus.
  • FIG. 18 shows photographs of HQPC activity at 1% and 2% plus control using TCBS and shrimp larvae macerates.
  • FIG. 19 shows photographs of HQPC activity at 0.5% plus control using ChromAgar and shrimp larvae macerates.
  • FIG. 20 graph showing inhibition (%) of V. parahaemolyticus in the presence of HQPC at 1% and 2% inclusion levels; incubation of Ohrs, 6hrs, 12hrs, 18hrs, an 24hrs in ChromAgar Vibrio.
  • FIG. 21 graph showing inhibition (%) of V. parahaemolyticus in the presence of HQPC at 5%, 10% and 15% inclusion levels; incubation in ChromAgar Vibrio.
  • FIG. 22 shows a picture of PCR amplification of V. parahaemolyticus.
  • FIG. 23 is a graph showing inhibition (%) of three commercial probiotics in the presence of HQPC at 1% and 2% inclusion levels; incubation in TSB.
  • FIG. 24 is a graph showing survival rates from shrimp feeding trial.
  • references to “a formulation” includes one or more formulations, and/or compositions of the type described herein which will become apparent to those persons skilled in the art upon reading this disclosure and so forth.
  • the HQPC as disclosed herein may be manufactured from non-GM soybeans, which makes it a perfect match for the European aqua industry.
  • a central problem that confronts sustainable RAS involves two interlocking limitations that the operators must balance to run successful aquaculture operations.
  • the first limitation involves an understanding of present-day water re-use systems that limit fish or shrimp production.
  • the second limitation centers on sustainable fish feeds where use of soy-based feeds in such present-day water re-uses systems make their management more difficult.
  • the resulting situation requires present day aquaculture farmers to balance the risk-benefit of each limitation so as to achieve profitability as well as fulfil the demands of their customers.
  • AHPND Acute Hepatopancreatic Necrosis Syndrome
  • EMS Early Mortality Syndrome
  • feed mismanagement As disclosed herein, low levels of HQPC inclusion in a feed composition (e.g., between about 1% to about 10%) can serve as an effective antibacterial against Vibrio to protect shellfish, even at high stocking density.
  • animal means any organism belonging to the kingdom Animalia and includes, without limitation, humans, birds (e.g., poultry), mammals (e.g., humans, cattle, swine, goat, sheep, cat, dog, mouse and horse) as well as aquaculture organisms such as fish (e.g., trout, salmon, perch), mollusks (e.g., clams) and crustaceans (e.g., crab, lobster, prawns and shrimp).
  • birds e.g., poultry
  • mammals e.g., humans, cattle, swine, goat, sheep, cat, dog, mouse and horse
  • aquaculture organisms such as fish (e.g., trout, salmon, perch), mollusks (e.g., clams) and crustaceans (e.g., crab, lobster, prawns and shrimp).
  • fish includes all vertebrate fish, which may be bony or cartilaginous fish.
  • Vibrio species include, but is not limited to, V. alginolyticus , V. parahaemolyticus, V. harveyi , V. vulnificus , V. diabolicus , V. dam sella, V.fischeri , V. anguillarum , V. campbelli , V. pelagians, V. orientalis, V. ordalii, V. mediterrani, and V. logei.
  • non-animal based protein means that the substance comprises at least 0.81 g of crude fiber/lOOg of composition (dry matter basis), which crude fiber is chiefly cellulose and lignin material obtained as a residue in the chemical analysis of vegetable substances.
  • low stocking density for shrimp means 5 to 25 individuals/m 2 in a pond or aquaculture tank.
  • medium stocking density for shrimp means 25 to 100 individuals/m 2 in a pond or aquaculture tank.
  • high stocking density for shrimp means 100 to 500 individuals/m 2 in a pond or aquaculture tank.
  • hyper-intensive stocking density for shrimp means greater than 500 individuals/m 2 in a pond or aquaculture tank.
  • incubation process means the provision of proper conditions for growth and development of bacteria or cells, where such bacteria or cells use biosynthetic pathways to metabolize various feed stocks.
  • the incubation process may be carried out, for example, under aerobic conditions.
  • the incubation process may include fermentation.
  • submerged fermentation means a method of manufacturing biomolecules in which enzymes and other reactive compounds are submerged in a liquid such as alcohol, oil or a nutrient broth.
  • the term "incubation products” means any residual substances directly resulting from an incubation process/reaction.
  • an incubation product contains microorganisms such that it has a nutritional content enhanced as compared to an incubation product that is deficient in such microorganisms.
  • the incubation products may contain suitable constituent(s) from an incubation broth.
  • the incubation products may include dissolved and/or suspended constituents from an incubation broth.
  • the suspended constituents may include undissolved soluble constituents (e.g., where the solution is supersaturated with one or more components such as proteins) and/or insoluble materials present in the incubation broth.
  • the incubation products may include substantially all of the dry solids present at the end of an incubation (e.g., by spray drying an incubation broth and the biomass produced by the incubation) or may include a portion thereof.
  • the incubation products may include crude material from incubation where a microorganism/solids/centrates/cakes may be fractionated and/or partially purified to increase the nutrient content of the material.
  • a “conversion culture” means a culture of microorganisms which are contained in a medium that comprises material sufficient for the growth of the microorganisms, e.g., water and nutrients.
  • the term "nutrient” means any substance with nutritional value. It can be part of an animal feed, foodstuff or food supplement for an animal.
  • Exemplary nutrients include but are not limited to proteins, peptides, fats, fatty acids, nucleic acids, lipids, water and fat soluble vitamins, essential amino acids, carbohydrates, sterols, enzymes and trace minerals, such as, phosphorus, iron, copper, zinc, manganese, magnesium, cobalt, iodine, selenium, molybdenum, nickel, fluorine, vanadium, tin, silicon and combinations thereof.
  • Conversion is the process of culturing microorganisms in a conversion culture under conditions suitable to convert protein/carbohydrate/polysaccharide materials, for example, soybean constituents into a high-quality protein concentrate.
  • Adequate conversion includes, but is not limited to, utilization of 90% or more of specified carbohydrates to produce microbial cell mass and/or exopolysaccharide, enzymes and microbial metabolites, specific reduction in oligosaccharide concentration, achieving a select degree of hydrolysis for proteins, seeing a specific %change in NIR spectra between 4664 cm 1 and 4836 cm 1 or a combination thereof.
  • conversion may be aerobic or anaerobic or a combination thereof.
  • a flocculent or “clearing agent” is a chemical that promotes colloids to come out of suspension through aggregation, and includes, but is not limited to, a multivalent ion and polymer.
  • a flocculent/clearing agent may include bioflocculents such as exopolysaccharides (e.g., pullulan).
  • formulation means a material or mixture prepared according to a particular prescription.
  • foodstuff means a substance suitable for consumption as a nutritious composition that humans or animals eat or drink or that plants absorb in order to maintain life and growth.
  • centrate means the liquid leaving a hydrodynamic force application after most of the solids have been removed, the resulting dry product is termed "cake.”
  • suspension means a heterogeneous mixture that contains solid particles sufficiently large for sedimentation.
  • evaporation means the process of turning from liquid into vapor.
  • evaporation is a process that involves a change in the state of matter while distillation is a process of separation. Both these processes may be used for various purposes. While the vaporization in evaporation occurs below the boiling point, the vaporization in distillation occurs at the boiling point.
  • exopolysaccharides means high-molecular-weight polymers comprising sugar residues that are generated by a microorganism and released into the surrounding environment, which high-molecular weight polymers include anabolic and metabolic products.
  • DH degree of hydrolysis
  • trypsin inhibitor unit means the amount of trypsin inhibitor in a sample.
  • a method may use N-benzoyl-DL-arginine />-nitroanilide as a chromogenic substrate for trypsin, and the ability of aliquots of soy meal extract to inhibit the activity of trypsin towards this substrate is utilized to estimate the amount of trypsin inhibitor in a soy meal sample.
  • the amount of / nitroaniline formed during a 10-min incubation is measured spectrophotometrically, and the absorbance values in the presence and absence of soy extract are used in calculations that give a number for trypsin inhibitor units (TIU) per gram of original soy sample.
  • TIU trypsin inhibitor units
  • AP4 toxin refers to the Pir vp A gene product (see e.g., GenBank Accession No. A0551083.1).
  • “meat substitute” or “meat analog” means a composition that approximates certain aesthetic qualities (primarily texture, flavor and appearance) or chemical characteristics of a specific meat.
  • such substitutes or analogs include, but are not limited to, dairy-based: paneer cheese, glamorgan sausage, paneer; fungi-derived: edible mushrooms, mycoprotein, fistulina hepatica, lyophyllum decastes; fruit-based: tempeh, breadfruit, coconut burger, green jackfruit pulp, eggplant, jackfruit; legumes: Burmese tofu, falafel, ganmodoki, koya-dofu, oncom (red oncom and black oncom), tempeh burger, textured vegetable protein, tofurkey or faux turkey, vegetarian bacon, vegetarian hot dog, vegetarian sausage, and bakery burger.
  • the protein concentrate as disclosed herein is combined with meat substitutes.
  • NIR near-infrared spectroscopy
  • hydrodynamic force means energy acting on solid bodies immersed in fluids and in motion relative to said fluids.
  • such force may be applied through processes, including, but not limited to, centrifugation and filtration.
  • cellulose deconstructing enzymes means enzymes that act by hydrolyzing, inter alia , glycosidic bonds of linear glucose b-1 ,4-linked polymers, producing glucose and other simple or complex sugars.
  • antifomate or "defoamer,” including grammatical variations thereof, is a chemical additive that reduces and hinders the formation of foam in industrial process liquids.
  • such chemicals include, but are not limited to, oil based defoamers; powder defoamers; water based defoamers, silicone based defoamers; EO/PO based defoamers and alkyl polyacrylates.
  • such a defoamer includes water-based food-grade emulsion designed to control foam in aqueous food-canning processes, non-aqueous silicone-free defoamer that utilizes defoaming polymers and biodegradable oils, and food-grade 100% active food-grade kosher defoamer designed to destroy foam in aqueous environments including food manufacturing, fermentation, agricultural and industrial-grade processes.
  • PPD predicted apparent protein digestibility
  • room temperature is about 25°C under standard pressure.
  • fertilizer is a measure of the ratio of the difference of the ingested and fecal nitrogen to the ingested nitrogen, expressed as a percentage.
  • fertilizer means a product generated from plant-based material that has been incubated with one or more microorganisms, including, but not limited to, bacteria and fungi.
  • HQPC means high quality protein concentrate from one or more fermented plant-based materials. Such HQPC may be used as a feed, feedstock, alone or in combination with other feed or feedstock constituents, a pro-biotic, or a constituent thereof, including as a means to deliver nutraceuticals and/or pharmaceuticals to animals.
  • the protein content of the HQPC may be about 60% to about 65%, about 65% to about 70%, about 70% to about 75% or greater (dry matter basis (dmb)).
  • solvent means a substance, ordinarily a liquid, in which other materials dissolve to form a solution.
  • Polar solvents e.g., water, aqueous solutions
  • nonpolar solvents e.g., hydrocarbons
  • Solvents may be predominantly acidic, predominantly basic, amphoteric, or aprotic.
  • Organic compounds used as solvents include, but are not limited to, aromatic compounds and other hydrocarbons, alcohols, esters, ethers, ketones, amines, and nitrated and halogenated hydrocarbons.
  • a large number of plant protein sources may be used in connection with the present disclosure as feed stocks for conversion.
  • the main reason for using plant proteins in the feed industry is to replace more expensive protein sources, like animal protein sources.
  • Another important factor is the danger of transmitting diseases through feeding animal proteins to animals of the same species.
  • Examples for plant protein sources include, but are not limited to, protein from the plant family Fabaceae as exemplified by soybean and peanut, from the plant family Brassiciaceae as exemplified by canola, cottonseed, the plant family Asteraceae including, but not limited to sunflower, and the plant family Arecaceae including copra. These protein sources, also commonly defined as oilseed proteins may be fed whole, but they are more commonly fed as a by-product after oils have been removed.
  • plant protein sources include plant protein sources from the family Poaceae, also known as Gramineae, like cereals and grains especially com, wheat and rice or other staple crops such as potato, cassava, and legumes (peas and beans), some milling by-products including germ meal or corn gluten meal, or distillery /brewery by- products.
  • feed stocks for proteins include, but are not limited to, plant materials from soybeans, sorghum, peanuts, pulses, Rapeseeds, oats, barley, rye, canola, sesame seeds, cottonseeds, palm kernels, grape seeds, olives, safflowers, sunflowers, copra, com, coconuts, linseed, hazelnuts, wheat, rice, potatoes, cassavas, legumes, pennycress seeds, camelina seeds, mustard seeds, wheat germ meal, com gluten meal, com gluten feed, distillery /brewery by products, and combinations thereof.
  • the major proteins of plant origin reportedly used include, but are not limited to, soybean meal (SBM), maize gluten meal, Rapeseed/canola (Brassica sp.) meal, lupin (Lupinus sp.), for example, the proteins in kernel meals of de-hulled white (Lupinus albus), sweet (L. angustifolius) and yellow (L.
  • the protein sources may be in the form of non-treated plant materials and treated and/or extracted plant proteins.
  • heat treated soy products have high protein digestibility.
  • a protein material includes any type of protein or peptide.
  • soybean material or the like may be used such as whole soybeans.
  • Whole soybeans may be standard, commoditized soybeans; soybeans that have been genetically modified (GM) in some manner; or non-GM identity preserved (IP) soybeans.
  • GM soybeans include, for example, soybeans engineered to produce carbohydrates other than stachyose and raffmose.
  • Exemplary non-GM soybeans include, for example, Schillinger varieties that are line bred for low carbohydrates, and low trypsin inhibition.
  • High protein varieties include, but are not limited to, N2358 (Benson Hill Inc., St. Louis, MO).
  • soybean material examples include soy protein flour, soy protein concentrate, soybean meal and soy protein isolate, or mixtures thereof.
  • the traditional processing of whole soybean into other forms of soy protein such as soy protein flours, soy protein concentrates, soybean meal and soy protein isolates, includes cracking the cleaned, raw whole soybean into several pieces, typically six (6) to eight (8), to produce soy chips and hulls, which are then removed. Soy chips are then conditioned at about 60°C and flaked to about 0.25 millimeter thickness. The resulting flakes are then extracted with an inert solvent, such as a hydrocarbon solvent, typically hexane, in one of several types of countercurrent extraction systems to remove the soybean oil.
  • an inert solvent such as a hydrocarbon solvent, typically hexane
  • soy protein flours soy protein flours, soy protein concentrates, and soy protein isolates
  • the flakes resulting from this process are generally referred to as "edible defatted flakes" or "white soy(bean) flakes.”
  • White soy bean flakes which are the starting material for soy protein flour, soy protein concentrate, and soy protein isolate, have a protein content of approximately 50%.
  • White soybean flakes are then milled, usually in an open-loop grinding system, by a hammer mill, classifier mill, roller mill or impact pin mill first into grits, and with additional grinding, into soy flours with desired particle sizes. Screening is typically used to size the product to uniform particle size ranges, and can be accomplished with shaker screens or cylindrical centrifugal screeners. Other oil seeds may be processed in a similar manner.
  • Soybeans contain a small but very significant 2S albumin storage protein, in addition to glycinin and beta-conglycinin. Soybeans also contain biologically active or metabolic proteins, such as enzymes, trypsin inhibitors, hemagglutinins, and cysteine proteases very similar to papain.
  • soy products While soy products have high protein digestibility, the upper inclusion level for full fat or defatted soy meal inclusion in diets for carnivorous fish, for example, is between an inclusion level of 20 to 30%, even if heat labile antinutrients are eliminated.
  • soybean protein has shown that feeding fish with protein concentration inclusion levels over 30% causes intestinal damage and in general reduces growth performance in different fish species. In fact, most farmers are reluctant to use more than 10% plant proteins in the total diet due to these effects.
  • the present invention solves this problem and allows for plant protein inclusion levels of up to 40 or even 50%, depending on, amongst other factors, the animal species being fed, the origin of the plant protein source, the ratio of different plant protein sources, the protein concentration and the amount, origin, molecular structure and concentration of the glucan and/or mannan.
  • the plant protein inclusion levels are up to 40%, preferably up to 20 or 30%.
  • the plant protein present in the diet is between 5 and 40%, preferably between 1% and 2%, between 1% and 5%, between 5% and 10%, between 10% to 15%, or 15% and 30%.
  • percentages define the percentage amount of a total plant protein source in the animal feed or diet, this includes fat, ashes etc., and may be formulated for different purposes.
  • pure protein levels are up to 50%, typically up to 45%, in embodiments 5-95%.
  • the proportion of plant protein to other protein in the total feed or diet may be 5:95 to 95:5, 15:85 to 50:50, or 25:75 to 45:55.
  • HQPC in addition to feed diets, HQPC as disclosed herein may be formulated so as to be used with meat substitutes.
  • HQPC may be combined with fermented soy-based products.
  • fermented soy-based products include, but are not limited to, thawed and sliced frozen tofu; oncom, one of the traditional staple foods of West Java (Sundanese) cuisine of Indonesia, there are two types: red oncom and black oncom (oncom is closely related to tempeh; both are foods fermented using mold); soy protein; soy pulp, used for bakery burgers and croquettes); tempeh, a traditional Indonesian soy product made from fermented soybeans; textured vegetable protein, a defatted soy flour product that is a by-product of extracting soybean oil (it is often used as a meat analogue or meat extender, with a protein content that is comparable to certain meats); tofu (while not traditionally seen as a meat substitute in Asia, but widely used for that purpose
  • the HQPC-combined fermented soy product as disclosed may be used as a meat substitute alone, or may be combined with other meat substitutes or meat analogs to produce various products for human consumption, including various combinations comprising the examples above.
  • the addition of the HQPC is combined with various meat substitutes and/or meat analogues to improve texture, aroma, feel, bite, crunch, flavor or appearance of said meat substitute and/or meat analogue.
  • Such aesthetics may be determined, for example, using Caswell’s classification of food quality (see, e.g., Caswell, J Agr Res Econ (1998) 42:409-474).
  • the disclosed microorganisms must be capable of converting carbohydrates and other nutrients into a high-quality protein concentrate in the process as disclosed herein.
  • the microorganism is a yeast-like fungus.
  • An example of a yeast-like fungus is Aureobasidium pullulans.
  • Other example microorganisms include yeast such as Kluyveromyces and Pichia spp, Lactic acid bacteria, Trichoderma reesei, Pleurotus ostreatus, Rhizopus spp, and many types of lignocellulose degrading microbes.
  • exemplary microbes include those microbes that can metabolize stachyose, raffmose, starch, glucose, fructose, lactose, sucrose, xylose and other sugars. However, it is within the abilities of a skilled artisan to pick, without undue experimentation, other appropriate microorganisms based on the disclosed methods.
  • microorganisms exhibit low exopolysaccharide (e.g., pullulan) production, for example, low pullulan yield is considered less than about 3.0 g/L when grown in yeast extract (YE) containing media, where YE (as nitrogen source) is present between 0.35 and 0.5 g/L (see, e.g., Leathers et al., J Indus Micro (1988) 3:231-239; at p. 232, col. 2, third paragraph, and Table 3, incorporated herein by reference). While not being bound by theory, high exopolysaccharide producers generate final products that can be difficult to dry (e.g., extends drying time) and/or generate viscous products after drying.
  • YE yeast extract
  • the A. pullulans is adapted to various environments/stressors encountered during conversion.
  • the A. pullulans strain is selected from NRRL deposit Nos. Y-2311-1, Y-6754a, YB-4026, YB-4588, Y-6992, Y-17000, or Y-17001, and combinations thereof.
  • an A. pullulans strain denoted by NRRL deposit No. Y-2311-1 may be used as disclosed herein.
  • the microorganism may be identified using PCR.
  • the organism may be targeted by directing primers to the following nucleic acid sequence encoding alpha-arabinofuranosidase (Genbank Accession No.: AY495375):
  • primer pairs may be used to track and identify origin of products made by the methods described herein.
  • PCR may be carried out by standard methods (see, e.g., U.S. Pat. No. 4,800,159, herein incorporated by reference), although alternative PCR methods would be apparent to the skilled artisan.
  • the plant-based material may be blended with water and/or centrate to form a mash in one or more mix tanks at a solid loading rate of at least 5%, with pH adjusted to 4.5-4.9.
  • the pH is 4.8.
  • the mash may be treated with sulfuric acid and/or defoamers prior to application of hydrodynamic force to separate the suspension into a cake and centrate.
  • the cake may be further washed with one or more solvents (e.g., water or centrate) before transfer to a cook tube-cooler tandem device(s), where the residence time in the cook-tube may be varied. Temperature in the cook tube may be varied up to 121.1°C, and residence time may be varied from 0 up to 2 min. In one aspect, the residence time is about 1.5 mins.
  • the cooled mash is transferred to one or more fermenter vessels, and an inoculum of A. pullulans may be added to the mash, where the resulting inoculated mash may be incubated for about 7h to about 10 h, about 10 h to about 14h, about 14 h to about 20 h, or about 7 h to about 24 h, or until the degree of hydrolysis (DH) of 2% to 80% of protein is achieved. While not being bound by theory, DH is substantially due to enzyme hydrolysis rather than pyrolysis, including that DH may be greater with additional recycling of centrate from broth tank.
  • Inoculation volume (e.g., from a 60hr seed culture, approximately between about 1 x 10 1 to about 100 x 10 9 CFU/ml) may be about 1% of the working volume of the one or more fermenter vessels.
  • inoculated cells may have substantially unicellular morphology, and while not being bound by theory, use of cells with substantially filamentous morphology may result in decreased access to oxygen and other nutrients.
  • sterile air may be introduced into the reactor at a rate of 0.5-1 L/L/h.
  • the conversion culture undergoes conversion by incubation with the plant-based material for less than about 12 hours. In embodiments, the conversion culture will be incubated for between about 7 hours and about 14 hours. The conversion culture may be incubated at about 24-35°C.
  • the pH of the conversion culture while undergoing fermentation, may be about 4.5 to about 5.5. In embodiments, the pH of the conversion culture may be about 4.8. In embodiments, the conversion culture is actively aerated.
  • the fermented plant material is transferred from one or more incubating vessels to a broth tank, where it may be heated to about 60°C, from about 30 mins to 2 hr. Hydrodynamic force is applied to the heated-fermented plant material, which results in a fermented cake and fermented centrate.
  • the fermented cake is then dried to less than about 7% moisture, at a temperature of between about 37.8°C to about 149°C.
  • the fermented centrate may be transferred to one or more of the previously employed mix tanks (e.g., to conserve and recycle water, increase yield and protein content, including soluble proteins), to be mixed with incoming plant- based material, including that the fermented centrate may be transferred to an evaporator to produce a liquid protein concentrate.
  • Fermented centrate destined for the evaporator may be subject to two or more evaporation steps, where evaporation is carried out for a sufficient time and temperature to achieve a liquid protein concentrate having % solids from about 10 to about 60%.
  • the liquid protein concentrate may be transferred back to one or more of the mix tanks to ultimately form one or more additional centrates/cakes for processing.
  • the cakes/centrates may be washed and/or precipitated with ethanol.
  • final protein concentrations solids recovery may be modulated by plant-based feedstock, incubation conditions, pH, drying time and temperature. For example, about 70% protein or greater may be achieved for the ultimate dried cake with a 14 hr incubation, where the solids content of between about 76.59% to about 99.65% is obtained. Protein content in said cake may be from about 65% to about 70%, about 70% to about 75%, or about 75% to about 80% (dmb).
  • the feed stock may be treated with one or more antibiotics (e.g., but not limited to, tetracycline, penicillin, erythromycin, tylosin, virginiamycin, and combinations thereof) before inoculation with the converting microbe to avoid, for example, contamination by unwanted bacteria strains.
  • antibiotics e.g., but not limited to, tetracycline, penicillin, erythromycin, tylosin, virginiamycin, and combinations thereof
  • samples may be removed at regular intervals during processing (e.g., determine amino acids, DH, oligosaccharide concentration, pullulan content and the like).
  • samples for HPLC analysis may be boiled, centrifuged, filtered (e.g., through 0.22- pm filters), placed into autosampler vials, and frozen until analysis.
  • samples may be assayed for carbohydrates and organic solvents using a WATERS HPLC system, although other HPLC systems may be used.
  • WATERS HPLC system e.g., UPLC.
  • Samples may be subjected to plate or hemocytometer counts to assess microbial populations.
  • Samples may also be assayed for levels of cellulose, hemicellulose, lignin, starch, and pectin using National Renewable Energy Laboratory procedures.
  • FIGs. 6-9 illustrate production processes 100, 100(a), 100(b), 100(c) that may be used to generate HQPC as disclosed herein.
  • plant-based material is first subject to milling device 101, and subsequently transferred to first mix tank 102(a), where it is mixed with one or more first solvents, which first solvents may contain acids, bases, enzymes, defoamer, and/or centrate from a downstream separation step (e.g., centrate 2, during continuous cycling).
  • Enzymes include non-cellulose deconstructing enzymes (e.g., phytase, proteases and the like).
  • the resulting mash is separated from the one or more first solvents by hydrodynamic force device (e.g., decanting centrifuge) 103(a) to produce a first centrate and a first cake.
  • the first centrate may be transferred to evaporator 107 to produce soy solubles 108 (i.e., liquid protein concentrate).
  • the first cake is transferred to a second mix tank 102(b), where the first cake is washed with one or more second solvents and/or a downstream centrate (e.g., centrate 3, for continuous cycling).
  • the washed first cake is separated from the one or more second solvents by hydrodynamic force device 103(b) to produce a second centrate and a washed second cake.
  • the second centrate may be transferred to first mix tank 102(a) during continuous cycling.
  • the washed second cake is transferred to third mix tank 102(c), where the washed second cake is washed with one or more third solvents and/or a downstream centrate (e.g., centrate 3, for continuous cycling).
  • the washed second cake is separated from the one or more third solvents by hydrodynamic force device 103(c) to produce a third centrate and a washed third cake.
  • the third centrate may be transferred to second mix tank 102(b) during continuous cycling.
  • the washed third cake is transferred to fourth mix tank 102(d), where the washed third cake is washed with one or more third solvents and/or a condensate from evaporator 107 to form a suspension, which suspension is transferred to one or more fermenters 104 for inoculation by seed train 105.
  • the suspension Prior to incubation, the suspension may be heated and cooled in cook-tube/cooler tandem devices (not shown), where the residence time and temperature in said cook-tube may be modulated to change the characteristics of the final product (e.g., increase protein content).
  • the residence time may be 0 to about 5 secs, about 5 secs to about 10 secs, about 10 secs to about 15 secs, about 20 secs to about 30 secs, or about 30 secs to 1 min.
  • the suspension is heated in the cook-tube at a temperature of at least about 95°C, about 105°C, about 110°C, about 120°C, about 130°C, or about 140°C, where the suspension is cooled to between about 30° to 32°C prior to incubation with seed train 105.
  • the resulting fermented suspension is separated into a fourth centrate and final cake by application of hydrodynamic force device (e.g., decanting centrifuge/disc stack centrifuge) 103(d).
  • the suspension may be heated in a broth tank (not shown) to at least about 60°C, for about 30 mins to about 2 hr, prior to application of hydrodynamic force.
  • the resulting cake from 103(d) and/or the broth tank (not shown) is transferred to drier 106. Drying is carried out by heating drier 106 to about 150°C until the ultimate cake has a moisture content of less than about 7%.
  • the drawing provides a detail of the first steps of the production process 100(a) (centrate 1).
  • Plant-based material is first subject to milling device 101, and subsequently transferred to first mix tank 102(a), where it is mixed with one or more first solvents.
  • the resulting mash is separated from the one or more first solvents by hydrodynamic force device 103(a) to produce a first centrate and a first cake.
  • the first centrate may be transferred to evaporator 107 to produce soy solubles 108.
  • the drawing provides production process detail for centrate 4 100(b).
  • the washed third cake is transferred to fourth mix tank 102(d), where the washed third cake is washed with one or more third solvents and/or a condensate from evaporator 107 to form a suspension, which suspension is transferred to one or more fermenters 104 for inoculation. After incubation, the resulting fermented suspension is separated into a fourth centrate and final cake by application of hydrodynamic force device 103(d), where centrate 4 is transferred to an upstream mix tank (e.g., 102(c)).
  • an upstream mix tank e.g., 102(c)
  • production process 100(c) provides details relating to centrates 4 and 1, where centrate 4 is subject to disc stack centrifugation 109 and/or ultrafiltration 110 prior to transfer to mix tank 3 102(c), including that centrate 1 may be subject to de-sludge and de-oil, ultrafiltration 110 for protein separation, and/or nanofiltration 111 for sugar separation.
  • separation methods may be used to remove microbes used in the fermentation.
  • production process 100 100(a), 100(b),
  • 100(c) may be batch or continuous, and contain at minimum one wash cycle (from mill 101 to dryer 106), and at least two centrates, where one centrate is further processed to concentrate soy solubles 108.
  • the feed stock prior to milling and the final product are analyzed by NIR spectroscopy.
  • the shift downward should be at least about a 10% change, between about a 10% to about a 15% change, or between about a 15% change and about a 20% change or greater, calculated using the equation:
  • the percent change in downward shift was about 16.7% for an SBM sample and a final ME-PRO ® (HSPQ product) sample from which it was produced. While not being bound by theory, such a shift is indicative of increased protein content (see, e.g., Fan et al., PLoS ONE (2016) ll(9):e0163145. doi: 10.1371/journal pone.0163145).
  • NIR spectrum data may be generated using the methods as disclosed in Fan et al. ((2016); herein incorporated by reference in its entirety), however, the skilled artisan would recognize that other suitable methods, including any associated hardware and software, are available.
  • the HQPC recovered from the conversion culture that has undergone conversion is used in dietary formulations.
  • the recovered HQPC may be the only protein source in the dietary formulation. Protein source percentages in dietary formulations are not meant to be limiting and may include 24 to 80% protein concentrate.
  • HQPC will be more than about 50%, more than about 60%, or more than about 70% of the total dietary formulation protein source.
  • Recovered HQPC may replace/supplement protein sources such as fish meal, soybean meal, wheat and corn flours and glutens and concentrates, and animal byproduct such as blood, poultry, meat substitutes, meat analogs, and feather meals. Dietary formulations using HQPC may also include supplements such as mineral and vitamin premixes to satisfy remaining nutrient requirements as appropriate.
  • performance of the HQPC may be measured by comparing the growth, feed conversion, protein efficiency, DH, APD, PPD, and survival of animal on a high-quality protein concentrate dietary formulation to animals fed control dietary formulations, including aesthetics for foodstuff for human consumption.
  • test formulations contain consistent protein, lipid, and energy contents. For example, when the animal is a fish, viscera (fat deposition) and organ (liver and spleen) characteristics, dress-out percentage, and fillet proximate analysis, as well as intestinal histology (enteritis) may be measured to assess dietary response.
  • viscera (fat deposition) and organ (liver and spleen) characteristics, dress-out percentage, and fillet proximate analysis, as well as intestinal histology (enteritis) may be measured to assess dietary response.
  • in vitro DH, PPD, and ADP may be measured to assess dietary response.
  • gut infections characterized with diarrhea are the major cause of reduced growth performance and increased morbidity and mortality
  • individual dietary formulations containing the recovered HQPC may be optimized for different kinds of animals.
  • the animals include, but are not limited to, fin-fish, crustaceans (e.g., shrimp, crabs, prawns, and lobsters), domestic animals (e.g., dogs, cats, birds) and farm animals (e.g., cattle, pigs, and chickens).
  • the animals are fin-fish and crustaceans that are grown in commercial aquaculture.
  • the crustaceans include juvenile shrimp.
  • Complete grower diets may be formulated using HQPC in accordance with known nutrient requirements for various animal species.
  • the formulation may be used for yellow perch (e.g., 42% protein, 8% lipid).
  • the formulation may be used for rainbow trout (35% protein, 16% lipid).
  • the formulation may be used for any one of the animals recited supra.
  • Basal mineral and vitamin premixes for plant-based diets may be used to ensure that micro-nutrient requirements will be met. Any supplements (as deemed necessary by analysis) may be evaluated by comparing to an identical formulation without supplementation; thus, the feeding trial may be done in a factorial design to account for supplementation effects.
  • feeding trials may include a fish meal-based control diet and ESPC- and LSPC- based reference diets [traditional SPC (TSPC) is produced from solvent washing soy flake to remove soluble carbohydrate; texturized SPC (ESPC) is produced by extruding TSPC under moist, high temperature; and low-antigen SPC (LSPC) is produced from TSPC by altering the solvent wash and temperature during processing].
  • TSPC traditional SPC
  • EPC texturized SPC
  • LSPC low-antigen SPC
  • Pellets for feeding trials may be produced using a single screw extruder (e.g., BRABENDERPLASTI-CORDER EXTRUDER Model
  • a replication of four experimental units per treatment may be used (e.g., about 60 to 120 days each).
  • Trials may be carried out in 110-L circular tanks (20 fish/tank) connected in parallel to a closed-loop recirculation system driven by a centrifugal pump and consisting of a solids sump, and bioreactor, filters (100 m ⁇ h bag, carbon and ultra-violet).
  • Heat pumps may be used as required to maintain optimal temperatures for species-specific growth.
  • Water quality e.g., dissolved oxygen, pH, temperature, ammonia and nitrite
  • experimental diets may be delivered according to fish size and split into two to five daily feedings. Growth performance may be determined by total mass measurements taken at one to four weeks (depending upon fish size and trial duration); rations may be adjusted in accordance with gains to allow satiation feeding and to reduce waste streams. Consumption may be assessed biweekly from collections of uneaten feed from individual tanks. Uneaten feed may be dried to a constant temperature, cooled, and weighed to estimate feed conversion efficiency. Protein and energy digestibilities may be determined from fecal material manually stripped during the midpoint of each experiment or via necropsy from the lower intestinal tract at the conclusion of a feeding trial.
  • Survival, weight gain, growth rate, health indices, feed conversion, protein and energy digestibilities, and protein efficiency may be compared among treatment groups.
  • Proximate analysis of necropsied fishes may be carried out to compare composition of fillets among dietary treatments. Analysis of amino and fatty acids may be done as needed for fillet constituents, according to the feeding trial objective. Feeding trial responses of dietary treatments may be compared to a control (e.g., fish meal) diet response to ascertain whether performance of HQPC diets meet or exceed control responses.
  • a control e.g., fish meal
  • the RAS testing system may consist of Comeli-style dual drain tanks, solids settling tanks, mechanical dram filtration, moving bed bioreactor (MBBR), UV sterilization, chilling, and oxygen injection. Water quality may be monitored on a daily basis to ensure all parameters are within acceptable ranges (see, e.g., White et al., Aqua Mar Bio Eco (2020) JAMBE: 105, herein incorporated by reference).
  • shrimp may be analyzed to determine direct effects of HQPC such as providing significant amounts of biologically-active factors that can increase gut micro-biota, reduce intestinal-inflammation and boost metabolic processes for improved animal health, which may depend, inter alia, on dry matter conversion of feed to weight, where the determination of digestibility plays a key role.
  • in vitro protein digestion with standardized digestive enzymes recovered from shrimp may be used, including using the data from such analysis to determine DH, PPD and APD, as well as overall survival.
  • the present disclosure proposes to convert fibers and other carbohydrates in plant-based materials into additional protein using, for example, a GRAS-status microbe.
  • a microbial exopolysaccharide e.g., glucans
  • This microbial gum may also provide immunostimulant activity to activate innate defense mechanisms that protect animals from common pathogens resulting from stressors.
  • Immunoprophylactic substances such as b- glucans, bacterial products, and plant constituents, are increasingly used in commercial feeds to reduce economic losses due to infectious diseases and minimize antibiotic use.
  • the microbes of the present disclosure also produce extracellular peptidases, which should increase protein digestibility and absorption during metabolism, providing higher feed efficiency and yields.
  • this microbial incubation process provides a valuable, sustainable plant-protein based feed that is less expensive per unit of protein than SBM, SPC, and animal feeds.
  • the centrate components can be subjected further afterwards to an evaporation step that can concentrate soluble coproducts, such as sugars, glycerol, proteins, peptides and amino acids, into a material called syrup or condensed plant based solubles (PBS).
  • soluble coproducts such as sugars, glycerol, proteins, peptides and amino acids
  • the instant microbes may metabolize the individual carbohydrates in plant-based materials, producing both cell mass (protein), a microbial gum (e.g., pullulan), enzyme production, microbial metabolite production, and probiotics.
  • Various strains of these microbes also enhance fiber deconstruction.
  • the microbes of the present invention may also convert plant-based material proteins into more digestible peptides and amino acids (electro here FIG 12).
  • the following actions may be performed: 1) determining the efficiency of using select microbes of the present disclosure to convert plant based materials, yielding a high quality protein concentrate (HQPC) with a protein concentration of at least between about 65% to about 70% or greater, and 2) assessing the effectiveness of HQPC in replacing animal- based protein.
  • optimizing process/conversion conditions may be carried out to improve the performance and robustness of the microbes, test the resultant grower feeds for a range of commercially important animals, validate process costs and energy requirements for commercialization.
  • the HQPC of the present disclosure may be able to replace at least 50% of animal proteins, while providing increased growth rates and conversion efficiencies. For example, production costs should be less than commercial soy protein concentrate (SPC) and substantially less than fish meal.
  • Figures 1, 2 and 6-9 show various approaches of the present disclosure in the treatment of a plant based product, converting sugars into cell mass (protein) and gum, recovering HQPC and generating aqua feeds, and testing the resulting aqua feeds in fish feeding trials.
  • cellulose-deconstructing enzymes/pullulanases may be evaluated to generate sugars, which microbes of the present disclosure may convert to protein, exopolysaccharides and gum.
  • sequential omission of these enzymes and evaluation of co-culturing with cellulolytic microbes may be used.
  • Ethanol may be evaluated to wash the various cakes, precipitate the gum and improve recovery of protein solubles that may be suspended in various centrates through processing to generate HQPC. After drying, the HQPC may be incorporated into practical diet formulations.
  • test grower diets may be formulated (with mineral and vitamin premixes) and comparisons to an animal protein control and commercial plant-based protein concentrate/isolate based diets in feeding trials with commercially important animals may be performed.
  • Performance e.g., growth, feed conversion, protein efficiency, survival
  • viscera characteristics e.g., gut affects, and intestinal histology may be examined to assess responses.
  • optimizing the HQPC production process by determining optimum conversion conditions while minimizing process inputs, improving the performance and robustness of the microbe, testing the resultant grower feeds for a range of commercially important animals, and validating/updating process costs and energy requirements may be conducted.
  • low oil DDGS may be used as a substrate for conversion, where such low oil DDGS has a higher protein level than conventional DDGS.
  • low oil DDGS increase growth rates of A. pullulans compared to conventional DDGS.
  • fish that can be fed the fish feed composition of the present disclosure include, but are not limited to, Siberian sturgeon, Sterlet sturgeon, Starry sturgeon, White sturgeon, Arapaima, Japanese eel, American eel, Short-finned eel, Long-finned eel, European eel, Chanos chanos, Milkfish, Bluegill sunfish, Green sunfish, White crappie, Black crappie, Asp, Catla, Goldfish, Crucian carp, Mud carp, Mrigal carp, Grass carp, Common carp, Silver carp, Bighead carp, Orangefm labeo, Roho labeo, Hoven's carp, Wuchang bream, Black carp, Golden shiner, Nilem carp, White amur bream, Thai silver barb, Java, Roach, Tench, Pond loach, Bocachico, Dorada, Cachama, Cachama Blanca,
  • crustaceans that can be fed the feed composition of the present disclosure include, but are not limited to, Kadal shrimp, endeavour shrimp, greasyback shrimp, speckled shrimp, northern brown shrimp, fleshy prawn, brown tiger prawn, Indian white prawn, Kuruma prawn, caramote prawn, banana prawn, giant tiger prawn, southern pink shrimp, Sao Paulo shrimp, redtail prawn, southern white shrimp, Green tiger prawn, Northern white shrimp, Blue shrimp, Southern brown shrimp, Whiteleg shrimp, Atlantic seabob, Akiami paste shrimp, Monsoon river prawn, giant river prawn, common prawn, American lobster, European lobster, noble crayfish, Danube crayfish, signal crayfish, red swamp crawfish, yabby crayfish, red claw crayfish, marron crayfish, longlegged spiny lobster, gazami crab, Indo-
  • farm animals that can be fed the feed composition of the present disclosure include, but are not limited to, cattle, sheep, goats, deer, horses, chickens, pigs, rabbits, ducks, alpaca, emus, turkeys, bison, and camels.
  • domestic animals that can be fed the feed compositions of the present disclosure include, but are not limited to, dogs, cats, parrots, gold fish, turtles, parakeets, hamsters, lab rats, guinea pigs, and lab mice.
  • the feed composition of the present disclosure may be used as a convenient carrier for pharmaceutically active substances including, but not limited to, antibiotics, chemotherapeutics, anti-inflammatories, NSAIDs, antimicrobial agents and immunologically active substances including vaccines against bacterial or viral infections, and any combination thereof.
  • the feed composition according to the present disclosure may be provided as a liquid, pourable emulsion, or in the form of a paste, or in a dry form, for example as a granulate, a powder, or as flakes.
  • a lipid-in-water emulsion it may be in a relatively concentrated form.
  • Such a concentrated emulsion form may also be referred to as a pre-emulsion as it may be diluted in one or more steps in an aqueous medium to provide the final enrichment medium for the organisms.
  • cellulosic-containing starting material for the microbial-based process as disclosed is com.
  • Com is about two-thirds starch, which is converted during a fermentation and distilling process into ethanol and carbon dioxide. The remaining nutrients or fermentation products may result in condensed distiller's solubles or distiller's grains such as DDGS, which can be used in feed products.
  • the process involves an initial preparation step of dry milling or grinding of the com.
  • the processed corn is then subjected to hydrolysis and enzymes added to break down the principal starch component in a saccharification step.
  • the following step of fermentation is allowed to proceed upon addition of a microorganism (e.g., yeast) provided in accordance with an embodiment of the disclosure to produce gaseous products such as carbon dioxide.
  • a microorganism e.g., yeast
  • the fermentation is conducted for the production of ethanol which can be distilled from the fermentation broth.
  • the remainder of the fermentation medium can be then dried to produce fermentation products including DDGS.
  • This step usually includes a solid/liquid separation process by centrifugation wherein a solid phase component can be collected. Other methods including filtration and spray dry techniques can be employed to effect such separation.
  • the liquid phase components can be subjected further afterwards to an evaporation step that can concentrate soluble coproducts, such as sugars, glycerol, proteins, peptides and amino acids, into a material called syrup or condensed com solubles (CCS).
  • CCS condensed com solubles
  • the CCS can then be recombined with the solid phase component to be dried as incubation products (DDGS).
  • DDGS incubation products
  • incubation products produced according to the present disclosure have a higher commercial value than the conventional fermentation products.
  • the incubation products may include enhanced dried solids with improved amino acid and micronutrient content.
  • a "golden colored" product can be thus provided which generally indicates higher amino acid digestibility compared to darker colored HQSP.
  • a light- colored HQSP may be produced with an increased lysine concentration in accordance with embodiments herein compared to relatively darker colored products with generally less nutritional value.
  • the color of the products may be an important factor or indicator in assessing the quality and nutrient digestibility of the fermentation products or HQSP. Color is used as an indicator of exposure to excess heat during drying causing caramelization and Millard reactions of the free amino groups and sugars, reducing the quality of some amino acids.
  • Another aspect of the present invention is directed towards complete feed compositions with an enhanced concentration of nutrients which includes microorganisms characterized by an enhanced concentration of nutrients such as, but not limited to, fats, fatty acids, lipids such as phospholipid, vitamins, essential amino acids, peptides, proteins, carbohydrates, sterols, enzymes, and trace minerals such as, iron, copper, zinc, manganese, cobalt, iodine, selenium, molybdenum, nickel, fluorine, vanadium, tin, silicon, and combinations thereof.
  • the process makes available a greater amount of phosphorous to the animal in a manner that does not lead to substantial contamination of waste water.
  • the incubation products obtained after the incubation process are typically of higher commercial value.
  • the incubation products contain microorganisms that have enhanced nutrient content than those products deficient in the microorganisms.
  • the microorganisms may be present in an incubation system, the incubation broth and/or incubation biomass.
  • the incubation broth and/or biomass may be dried (e.g., spray-dried), to produce the incubation products with an enhanced content of the nutritional contents.
  • the spent, dried solids recovered following the incubation process are enhanced in accordance with the disclosure.
  • These incubation products are generally non-toxic, biodegradable, readily available, inexpensive, and rich in nutrients.
  • the choice of microorganism and the incubation conditions are important to produce a low toxicity or non-toxic incubation product for use as a feed or nutritional supplement, including selection of a microorganism that does not produce metabolites in concentrations that would otherwise negatively affect the process.
  • glucose is the major sugar produced from the hydrolysis of the starch from grains, it is not the only sugar produced in carbohydrates generally.
  • the subject nutrient enriched incubation products produced by enzymatic hydrolysis of the non-starch carbohydrates are more palatable and digestible to the non-ruminant.
  • the nutrient enriched incubation product of this disclosure may have a nutrient content of from at least about 1% to about 95% by weight.
  • the nutrient content is preferably in the range of at least about 10%-20%, 20%-30%, 30%-40%, 40%-50%, 50%-60%, 60%-70%, and 70%- 80% by weight.
  • the available nutrient content may depend upon the animal to which it is fed and the context of the remainder of the diet, and stage in the animal life cycle. For instance, beef cattle require less histidine than lactating cows. Selection of suitable nutrient content for feeding animals is well known to those skilled in the art.
  • the incubation products may be prepared as a spray-dried biomass product.
  • the biomass may be separated by known methods, such as centrifugation, filtration, separation, decanting, a combination of separation and decanting, ultrafiltration or microfiltration.
  • the biomass incubation products may be further treated to facilitate rumen bypass.
  • the biomass product may be separated from the incubation medium, spray-dried, and optionally treated to modulate rumen bypass, and added to feed as a nutritional source.
  • the nutritionally enriched incubation products may also be produced in transgenic plant systems. Methods for producing transgenic plant systems are known in the art.
  • the nutritionally-enriched broth may be separated from the biomass produced by the incubation and the clarified broth may be used as an animal feed ingredient, e.g., either in liquid form or in spray dried form.
  • the incubation products obtained after the incubation process using microorganisms may be used as an animal feed or as food supplement for humans.
  • the incubation product includes at least one ingredient that has an enhanced nutritional content that is derived from a non-animal source (e.g., a bacteria, yeast, and/or plant).
  • the incubation products are rich in at least one or more of fats, fatty acids, lipids such as phospholipid, vitamins, essential amino acids, peptides, proteins, carbohydrates, sterols, enzymes, and trace minerals such as, iron, copper, zinc, manganese, cobalt, iodine, selenium, molybdenum, nickel, fluorine, vanadium, tin and silicon.
  • the peptides contain at least one essential amino acid.
  • the essential amino acids are encapsulated inside a subject modified microorganism used in an incubation reaction.
  • the essential amino acids are contained in heterologous polypeptides expressed by the microorganism.
  • the heterologous polypeptides are expressed and stored in the inclusion bodies in a suitable microorganism (e.g., fungi).
  • the incubation products have a high nutritional content. As a result, a higher percentage of the incubation products may be used in a complete animal feed.
  • the feed composition comprises at least about 15% of incubation product by weight. In a complete feed, or diet, this material will be fed with other materials.
  • the modified incubation products may range from 15% of the feed to 100% of the feed.
  • the subject incubation products may provide lower percentage blending due to high nutrient content. In other embodiments, the subject incubation products may provide very high fraction feeding, e.g. over 75%.
  • the feed composition comprises at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, at least about 45%, at least about 50%, at least about 60%, at least about 70%, or at least about 75% of the subject incubation products.
  • the feed composition comprises at least about 1% to 2%, or 5% to 10%, or 20% of incubation product by weight. More commonly, the feed composition comprises at least about 1% to 2%, or 5% to 10%, 10-15%, 15-25%, 25-20%, 20-25%, 30%-40%, 40%-50%, 50%-60%, or 60%-70% by weight of incubation product.
  • the subject incubation products may be used as a sole source of feed.
  • a dietary formulation as disclosed herein may have enhanced amino acid content with regard to one or more essential amino acids for a variety of purposes, e.g., for weight increase and overall improvement of the animal's health.
  • the formulations may have an enhanced amino acid content because of the presence of free amino acids and/or the presence of proteins or peptides including an essential amino acid, in the incubation products.
  • Essential amino acids may include histidine, lysine, methionine, phenylalanine, threonine, taurine, isoleucine, and/or tryptophan, which may be present in the formulation as a free amino acid or as part of a protein or peptide that is rich in the selected amino acid.
  • At least one essential amino acid-rich peptide or protein may have at least 1% essential amino acid residues per total amino acid residues in the peptide or protein, at least 5% essential amino acid residues per total amino acid residues in the peptide or protein, or at least 10% essential amino acid residues per total amino acid residues in the protein.
  • a formulation as disclosed herein may contain an enhanced content of an essential amino acid, may have an essential amino acid content (including free essential amino acid and essential amino acid present in a protein or peptide) of at least 2.0 wt % relative to the weight of the crude protein and total amino acid content, and more suitably at least 5.0 wt % relative to the weight of the crude protein and total amino acid content.
  • a feed formulation as disclosed herein includes other nutrients derived from microorganisms including but not limited to, fats, fatty acids, lipids such as phospholipid, vitamins, carbohydrates, sterols, enzymes, and trace minerals.
  • a feed formulation as disclosed herein may include complete feed form composition, concentrate form composition, blender form composition, and base form composition. If the formulation is in the form of a complete feed, the percent nutrient level, where the nutrients are obtained from the microorganism in an incubation product, which may be about 10 to about 25 percent, more suitably about 14 to about 24 percent; whereas, if the formulation is in the form of a concentrate, the nutrient level may be about 30 to about 50 percent, more suitably about 32 to about 48 percent.
  • the nutrient level in the composition may be about 20 to about 30 percent, more suitably about 24 to about 26 percent; and if the formulation is in the form of a base mix, the nutrient level in the formulation may be about 55 to about 65 percent. Unless otherwise stated herein, percentages are stated on a weight percent basis. If the HQPC is high in a single nutrient, e.g., Lys, it will be used as a supplement at a low rate; if it is balanced in amino acids and Vitamins, e.g., vitamin A and E, it will be a more complete feed and will be fed at a higher rate and supplemented with a low protein, low nutrient feed stock, like corn stover.
  • HQPC is high in a single nutrient, e.g., Lys, it will be used as a supplement at a low rate; if it is balanced in amino acids and Vitamins, e.g., vitamin A and E, it will be a more complete feed and will be fed at a higher
  • the feed formulation as disclosed herein may include a peptide or a crude protein fraction present in an incubation product having an essential amino acid content of at least about 2%.
  • a peptide or crude protein fraction may have an essential amino acid content of at least about 3%, at least about 5%, at least about 10%, at least about 15%, at least about 20%, at least about 30%, at least about 40%, and in embodiments, at least about 50%.
  • the peptide may be 100% essential amino acids.
  • a fish meal formulation may include a peptide or crude protein fraction present in an incubation product having an essential amino acid content of up to about 10%. More commonly, the fish meal formulation may include a peptide or a crude protein fraction present in an incubation product having an essential amino acid content of about 2-10%, 3.0-8.0%, or 4.0-6.0%.
  • the formulation as disclosed herein may include a peptide or a crude protein fraction present in an incubation product having a lysine content of at least about 2%.
  • the peptide or crude protein fraction may have a lysine content of at least about 3%, at least about 5%, at least about 10%, at least about 15%, at least about 20%, at least about 30%, at least about 40%, and in embodiments, at least about 50%.
  • a fish meal formulation may include the peptide or crude protein fraction having a lysine content of up to about 10%.
  • the fish meal formulation may include the peptide or a crude protein fraction having a lysine content of about 2-10%, 3.0-8.0%, or 4.0-6.0%.
  • the formulation as disclosed herein may include nutrients in the incubation product from about 1 g/Kg dry solids to 900 g/Kg dry solids.
  • nutrients in a fish meal formulation may be present to at least about 2 g/Kg dry solids, 5 g/Kg dry solids, 10 g/Kg dry solids, 50 g/Kg dry solids, 100 g/Kg dry solids, 200 g/Kg dry solids, and about 300 g/Kg dry solids.
  • the nutrients may be present to at least about 400 g/Kg dry solids, at least about 500 g/Kg dry solids, at least about 600 g/Kg dry solids, at least about 700 g/Kg dry solids, at least about 800 g/Kg dry solids and/or at least about 900 g/Kg dry solids.
  • the formulation as disclosed herein may include an essential amino acid or a peptide containing at least one essential amino acid present in an incubation product having a content of about 1 g/Kg dry solids to 900 g/Kg dry solids.
  • the essential amino acid or a peptide containing at least one essential amino acid in a fish meal composition may be present to at least about 2 g/Kg dry solids, 5 g/Kg dry solids, 10 g/Kg dry solids, 50 g/Kg dry solids, 100 g/Kg dry solids, 200 g/Kg dry solids, and about 300 g/Kg dry solids.
  • the essential amino acid or a peptide containing at least one essential amino acid may be present to at least about 400 g/Kg dry solids, at least about 500 g/Kg dry solids, at least about 600 g/Kg dry solids, at least about 700 g/Kg dry solids, at least about 800 g/Kg dry solids and/or at least about 900 g/Kg dry solids.
  • the formulation as disclosed herein may contain a nutrient enriched incubation product in the form of a biomass formed during incubation and at least one additional nutrient component.
  • the formulation contains a nutrient enriched incubation product that is dissolved and suspended from an incubation broth formed during incubation and at least one additional nutrient component.
  • the formulation has a crude protein fraction that includes at least one essential amino acid-rich protein. The formulation may be prepared so as to deliver an improved balance of essential amino acids.
  • the complete formulation may contain HQPC and one or more ingredients such as wheat middlings ("wheat mids"), corn, soybean meal, com gluten meal, distiller's grains or distiller's grains with solubles, salt, macro-minerals, trace minerals and vitamins, generated with or without fermentation.
  • Other potential ingredients may commonly include, but not be limited to sunflower meal, malt sprouts and soybean hulls.
  • the blender formulation may contain wheat middlings, corn gluten meal, distiller's grains or distiller's grains with solubles, salt, macro-minerals, trace minerals and vitamins.
  • Alternative ingredients would commonly include, but not be limited to, com, soybean meal, sunflower meal, cottonseed meal, malt sprouts and soybean hulls.
  • the base form formulation may contain wheat middlings, corn gluten meal, and distiller's grains or distiller's grains with solubles.
  • Alternative ingredients would commonly include, but are not limited to, soybean meal, sunflower meal, malt sprouts, macro minerals, trace minerals and vitamins.
  • HUFAs Highly unsaturated fatty acids in microorganisms, when exposed to oxidizing conditions may be converted to less desirable unsaturated fatty acids or to saturated fatty acids.
  • saturation of omega-3 HUFAs may be reduced or prevented by the introduction of synthetic antioxidants or naturally-occurring antioxidants, such as beta-carotene, vitamin E and vitamin C, into the feed.
  • Synthetic antioxidants such as BHT, BHA, TBHQ or ethoxyquin, or natural antioxidants such as tocopherols, may be incorporated into the food or feed products by adding them to the products, or they may be incorporated by in situ production in a suitable organism.
  • Incubation products of the present disclosure may also be utilized as a nutritional supplement for human consumption where the process begins with human grade input materials, and human food quality standards are observed throughout the process.
  • Incubation product or the formulation as disclosed herein is high in nutritional content.
  • Nutrients such as, protein and fiber are associated with healthy diets.
  • Recipes may be developed to utilize incubation product or the complete feed of the disclosure in foods such as cereal, crackers, pies, cookies, cakes, pizza crust, summer sausage, meat balls, shakes, and in any forms of edible food.
  • a snack bar may include protein, fiber, germ, vitamins, minerals, from the grain, as well as nutraceuticals such as glucosamine, HUFAs, or co factors, such as Vitamin Q-10.
  • Formulations comprising the subject incubation products may be further supplemented with flavors.
  • the choice of a particular flavor will depend on the animal to which the feed is provided.
  • the flavors and aromas both natural and artificial, may be used in making feeds more acceptable and palatable. These supplementations may blend well with all ingredients and may be available as a liquid or dry product form.
  • Suitable flavors, attractants, and aromas to be supplemented in the animal feeds include but not limited to fish pheromones, fenugreek, banana, cherry, rosemary, cumin, carrot, peppermint, oregano, vanilla, anise, plus rum, maple, caramel, citrus oils, ethyl butyrate, menthol, apple, cinnamon, any natural or artificial combinations thereof.
  • the flavors and aromas may be interchanged between different animals.
  • a variety of fruit flavors, artificial or natural may be added to food supplements comprising the subject incubation products for human consumption.
  • the HQPC may be part of a kit to generate various formulations, including the HQPC, a label, at least one container and instruction on generating formulations depending on the animal. Further, such instructions may be available through a weblink.
  • the shelf-life of the incubation product or the complete feed of the present disclosure may typically be longer than the shelf life of an incubation product that is deficient in the microorganism.
  • the shelf-life may depend on factors such as, the moisture content of the product, how much air can flow through the feed mass, the environmental conditions and the use of preservatives.
  • a preservative may be added to the complete feed to increase the shelf life to weeks and months.
  • Other methods to increase shelf life include management similar to silage management such as mixing with other feeds and packing, covering with plastic or bagging. Cool conditions, preservatives and excluding air from the feed mass all extend shelf life of wet co products.
  • the complete feed can be stored in bunkers or silo bags. Drying the wet incubation product or complete feed may also increase the product's shelf life and improve consistency and quality.
  • the complete feed of the present disclosure may be stored for long periods of time.
  • the shelf life may be extended by ensiling, adding preservatives such as organic acids, or blending with other feeds such as soy hulls. Commodity bins or bulk storage sheds may be used for storing the complete feeds.
  • the HQPC as disclosed herein may have a shelf life of at least 2 years.
  • Figure 1 shows an approach to pre-treating white flakes, converting sugars into cell mass (proteinaceous material) and gum (e.g., exopolysaccharides), recovering HQSPC and generating aquafeeds (FIGs. 2 and 4), and testing resulting aquafeeds in fish feeding trials for a process.
  • White flakes were first subject to extrusion pretreatment (BRABENDER PLASTI- CORDER SINGLE SCREW EXTRUDER Model PL2000, hackensack, NJ) at 15% moisture content, 50° C, and 75 rpm to disrupt the structure and allow increased intrusion of hydrolytic enzymes during subsequent saccharification.
  • FIG. 5 shows glucose recovery using ppt method.
  • the system contained a 675 L bioreactor, a variable speed progressive cavity pump, a continuous flow centrifuge, and a 1 x 4 meter drying table.
  • Inoculum for use in the 675L bioreactor was prepared in two, 5L NEW BRUNSWICK BIOFLO 3 BIOREACTORS.
  • 8-10L quantities of inoculum was prepared by growing A. pullulans as described for 2-3 days. This material was used to inoculate larger quantities of extruded and saccharified white flake prepared in the 675L bioreactor. Following incubation, ethanol was added, the mash was centrifuged to recover the wet solids which were then dried and used in fish feeding trials.
  • the yield and composition of the HQSPC several parameters were observed that significantly affected solids recovery. In the large scale trials, the parameters as shown in Table 1 were varied.
  • the ethanol precipitation first method recovered about 97% of the solids (soybean solids, cells and gum) using a lab centrifuge (10,000g), with about 3% solids remaining in the fluid phase.
  • the centrifugation first method recovered about 81.7% of solids (soybean solids and cells), with ethanol precipitation of the supernatant recovering about 14.8% solids (exopolysaccharide), and about 3.5% solids remaining in the fluid.
  • HQPC from soy bean was obtained by the methods as substantially recited above and as illustrated in FIGs 6-9, for both a 3x wash and lx wash cycle. Comparison of resulting compositions for the ppt method (HQSPC Trial 5 and Trail 6), 3x wash and lx (HQPC) wash are shown in Table 2.
  • Example 3 Hydrolysis of soybean meal by temperature [00186] A 10% (w/v) soybean meal slurry was prepared using hexane extracted soybean meal in water. The pH of the slurry was set at 4.5 and the slurry was agitated to obtain mixing. The soybean slurry was heated at a temperature of 100°C before fermentation. The heated mash was incubated with the fermentative organism. The heated mash with no fermentative organism was treated with FLAVORZYME ® (Protease from Aspergillus niger , purchased from Sigma) at a loading rate of 30mg/g soybean meal and was used as control. The sample was incubated at 30°C for 12 hours. Post incubation, the samples were heated at 80°C for 2 minutes to inactivate the protease.
  • FLAVORZYME ® Protease from Aspergillus niger
  • N-acetyl cysteine (3.33% w/v) was prepared in boric acid buffer (0.12 M and pH 10.4). 16.67pL of the sample supernatant was added to lOOOmL of N-acetyl cysteine.
  • the absorbance was measured at 340nm. 6% (w/v) OPA solution was prepared in 96% (v/v) ethanol solution. 10 pL of the OPA solution was added to 305 pL of sample. The sample with OPA solution was incubated at room temperature for 15 minutes. The absorbance was measured at 340 nm. The following calculation was used to calculate the relative degree of hydrolysis (%) [A340 test (15)-A340 test (0)] xl00/ [A340 COntroi (15)-A340 COntoi (0)]. See Table 3.
  • a 10% (w/v) soybean meal slurry was prepared using hexane extracted soybean meal in water. The pH of the slurry was set at 4.5 and the slurry was agitated to obtain mixing. The soybean slurry was heated at a temperature of 100°C before fermentation. The heated mash was incubated with the fermentative organism. The heated mash with no fermentative organism was treated with FLAVORZYME ® at a loading rate of 30mg/g soybean meal and was used as control. The sample was incubated at 30°C for 12 hours. Post incubation, the samples were heated at 80°C for 2 minutes to inactivate the protease. [00189] Fermentation samples were collected at 0, 2, 4, 6, 8, 10 and 12 hours.
  • Example 5 Hydrolysis of the Soybean meal slurry prepared in centrate by fermentation
  • a 10% (w/v) soybean meal slurry was prepared using hexane extracted soybean meal in centrate from solid-liquid separation.
  • the pH of the slurry was set at 4.5 and the slurry was agitated to obtain mixing.
  • the soybean slurry was heated at a temperature of 100°C before fermentation.
  • the heated mash was incubated with the fermentative organism.
  • the heated mash with no fermentative organism was treated with FLAVORZYME ® at a loading rate of 30mg/g soybean meal was used as control.
  • the sample was incubated at 30°C for 12 hours. Post incubation the samples were heated at 80°C for 2 minutes to inactive the protease.
  • Example 5 Hydrolysis of the Soybean meal slurry with phytase addition by fermentation
  • a 10% (w/v) soybean meal slurry was prepared using hexane extracted soybean meal in water.
  • the pH of the slurry was set at 4.5 and the slurry was agitated to obtain mixing.
  • the soybean slurry was heated at a temperature of 100°C before fermentation.
  • the heated mash was incubated with the fermentative organism.
  • the heated mash with no fermentative organism was treated with FLAVORZYME ® at a loading rate of 30mg/g soybean meal was used as control.
  • the sample was incubated at 30°C for 12 hours. Post incubation the samples were heated at 80°C for 2 minutes to inactivate the protease.
  • Table 6 reflects the relative Degree of hydrolysis of soybean meal slurry with phytase by fermentation.
  • RG relative growth
  • SGR specific growth rate
  • the experiment was conducted in an 8,246 L recirculating aquaculture system (RAS).
  • the system was equipped with 35, 190 L semi-square tanks each equipped with a recirculating drain which withdrew water from the subsurface and a sludge drain which was affixed to the lowest point in the bottom at the center of the tank.
  • Each tank had forced air diffusers fed by a blower, a water inlet flow bar that controlled the direction of current, and covers which provided darkness to half of the tank and netting which allowed light to penetrate the other half of the tank.
  • the RAS was also equipped with a centrifugal water pump, bead filter, UV filter, biofilter,
  • a trial was conducted to determine the effectiveness of diets containing HQPC in mitigating the severity and impact of the Early Mortality Syndrome/ Acute Hepatopancreatic Necrosis Disease (EMS/AHPND) in shrimp.
  • the trial was conducted at the ShrimpVet Laboratory in Ho Chi Minh City, Vietnam and lasted 33 days including an adaption period for one day, twenty-one days of feeding period, one day of challenge, and following ten days of post-challenge.
  • Trials were carried out in 120L plastic tanks. All tanks were outfitted with an activated coral biological filter, aeration and covered with plastic cap to reduce the risk of cross contamination. Brackish water of 20 parts per thousand (ppt) of salinity was utilized in each trial. Shrimp were fed ad libitum with their respective diets with four meals per day during the trial. Feed consumption was recorded during the trial. Test diets included one basal diet and six treatment diets that contained HQPC (inclusion levels 10-30%). Feeding amount was adjusted depending on the biomass and actual feed consumption. Water quality parameters such as dissolved oxygen (DO), pH, and temperature were measured daily. Total ammonia nitrogen, nitrite, and alkalinity were measured twice a week.
  • DO dissolved oxygen
  • pH pH
  • alkalinity were measured twice a week.
  • SPF pathogen free shrimp
  • EHP Enterocytozoon hepatopenaeid
  • WSSV Whitespot syndrome virus
  • TSV Taura syndrome virus
  • IMNV Infectious myonecrosis virus
  • EMS/AHPND disease EMS/AHPND disease using PCR technique.
  • Nauplii were reared in a strict biosecurity facility.
  • Post-larvae were also checked again for important pathogenic agents including EHP, WSSV, TSV, IMNV, and EMS/AHPND disease using PCR technique. Post-larvae were grown in biosecurity conditions.
  • shrimp were weighed in-group to determine initial weight. The initial average shrimp weight was 0.56 ⁇ 0.04 grams.
  • An immersion challenge method was also used in this trial. Treatment tanks and positive controls, with total of 28 tanks were subjected to an immersion challenge. Tryptic Soy Broth +2% sodium chloride (TSB+) inoculated with a consistently virulent strain of Vibrio parahaemolyticus , incubated for 24 hours. The bacterial suspension was added into tanks to achieve the bacterial density measured by optical density absorbance (OD600 nm) at the density is expected to kill 90% in the positive control "LD90" within 10 days. Negative control (4 tanks total) was treated with sterile TSB+ added directly to the tanks. The challenge dosage was 3.25x105 CFU/mL which was lethal dose 90% (LD90). Standard histopathology, H&F stain was conducted in tissues of shrimp.
  • Formulated feeds are the major driver allowing intensification of production but are also the major source of N and P in RAS.
  • phosphorous is one of the most critical minerals when formulating aquaculture feeds for RAS projects.
  • HQPC contains 0.4% phosphorous (Table 7) and phytic acid concentration on the final product is on average less than 0.12 (g/lOOg).
  • Results of the study show a significant difference in the degree of hydrolysis (DH) of the test ingredients with shrimp digestive enzymes (Table 9), with the DH value obtained for HQPC exhibiting 42 percent more hydroly sable protein than soybean meal, and 33 percent more than soy protein concentrate.
  • DH degree of hydrolysis
  • Typical DH values of SBM ranged between 4.0 percent and 4.2 percent for dehulled or non-dehulled samples, respectively. Results from comparable pH stat studies on a set of more than 40 samples of SBMs from the main producer countries (India, Argentina, United States and Brazil), have shown DH values between 3.74 and 4.43 percent. [00223] Appropriate screening of novel ingredients is required to assess their potential nutritional value and variability. Various studies have shown that in vitro digestion of ingredients by enzymes from the target shrimp or fish species is associated with apparent protein digestibility (APD). For almost half a century, the pH-stat method has been used to monitor the effects of heat treatment on the initial rates of trypsin proteolysis of soy protein. Previous research has also demonstrated the relationship between apparent protein digestibility (APD) and in vitro DH in juvenile Pacific white shrimp.
  • API apparent protein digestibility
  • the average in vivo apparent digestibility coefficient for crude protein in L. vannamei is 85 to 90 percent.
  • the degree of hydrolysis (DH) of HQPC was estimated to be 7.18 percent and the predicted apparent protein digestibility (PPD) at 93.1percent.
  • HQPC values for DH and PPD are the highest determined among over 150 ingredients tested - higher than various fish meals, soy protein concentrates and non- GM soybean meal (Table 9).
  • Soybean meal (full fat, extmded) 87.10 2.72
  • Samples of HQPC (e.g., ME-PRO ® ) were obtained from Prairie AquaTech (Brookings, South Dakota). Sub-samples were resuspended in distilled water at the test doses.
  • TCBS Agar for the analysis of total Vibrio , Difco TCBS agar was prepared, supplemented with 2% sodium chloride and incubated at 35°C for 24 hours. The pH of a one- liter solution was adjusted to 8.6 and heated to boiling with frequent stirring for 2 minutes. The solution was then placed on sterile plates until the agar solidified and stored at 2-8°C until use.
  • ChromAgar Vibrio for V. parahaemolyticus and V. vulnificus , ChromAgar Vibrio medium was used. Powdered agar (74.7g). was dissolved in. 1 liter of distilled water, homogenized and heated to boiling at 100°C.
  • TSA Agar Teryptone Soy Agar: for isolation, purification and growth tests with probiotic strains, Difco TSA medium was used. Powdered agar (40g) was dissolved in 1 liter of distilled water. The solution was homogenized for 2 minutes and subsequently plated and autoclaved at 121 °C for 15 minutes.
  • TSB Stepticase Soy Broth: Difco TBS medium was used for the isolation, purification and growth tests with strains of V. parahaemolyticus , V. vulnificus and several commercial probiotics.
  • Powered agar (30g) was dissolved in 1 liter of distilled water. The solution was homogenized for 2 minutes and subsequently plated and autoclaved at 121°C for 15 minutes.
  • HQPC was added to all the agars and liquid media at three concentrations: 5%, 10% and 15%. All inclusions into the culture media at the indicated concentrations were used to measure the effect against V. parahaemolyticus and commercial probiotics from three companies.
  • Agar Inoculations shrimp post-larva (0. lg) were weighed, macerated and resuspended in 200 pi of sterile distilled water. A 50 m ⁇ sample was inoculated in TCBS agar and ChromAgar. All Vibrio and probiotic bacteria were resuspended in TSB medium. A 50 m ⁇ sample was inoculated in TSA agar plates in the case of probiotics and ChromAgar for the Vibrio species.
  • CFU colony forming units
  • PCR Method DNA extraction and evaluation protocols were completed using a lysis buffer and PCR techniques (see, e.g., PCR Protocols - A Guide to Methods and Applications, (Innis, et al., eds.), 1990, Academic Press, Inc., San Diego, CA). Primers used followed the AP4 method (Dongtip et al., Aquaculture Reports (2015) 2:158-162, herein incorporated by reference) with three (3) sequences: FI (SEQ ID NO:22, 5' AT GAGT A AC A AT AT A A A AC AT GA A AC 3'), R1 (SEQ ID NO:23, 5' ACGATTTCGACGTTCCCCAA 3') and F2 (SEQ ID NO:24, 5'
  • HQSP shows inhibitory activity for Vibrio type 1 between 38%, 48% and 57%, respectively.
  • the inhibition rate was 78% and 100% for the 1% and 2% doses and for V. parahaemolyticus , 38%, 45% and 62%, respectively (FIG. 17).
  • Example 11 Inhibitory capacity of HQPC at including levels of 1% and 2% against V. parahaemolyticus bacteria present in macerates of shrimp larvae and inclusion in TBS culture media
  • V. parahaemolyticus Three EMS-associated strains were isolated from larval samples, grown on ChromAgar and TCBS and tested using PCR.
  • a strain of V. parahaemolyticus was cultured in liquid in liquid TSB medium with the inclusion of HQPC at 1% and 2%. Every 6 hours petri dishes were inoculated to verify the bacteria dynamics and the effect of MEPRO ® on bacteria growth. The results showed that HQPC at 1% and 2% at time zero had an inhibitory effect of 27%.
  • the growth of V. parahaemolyticus is compromised after the first 6 hours of culture for both dosages with a 40% reduction in growth. At 12 hours there is a slight recovery, and at 18 hours, the reactivation bacteria growth is back to normal (FIG. 20).
  • Example 12 Inhibitory capacity of HQPC at inclusion levels of 5%, 10% and 15% against V. parahaemolyticus and V. vulnificus bacteria present in macerates of shrimp larvae and inclusion in TSB culture media
  • V. vulnificus were isolated from larval samples with disease signs and used in this example. In Ecuador, the association of V. parahaemolyticus and V. vulnificus at levels of 10 4 CFU has been determined to be the cause of high mortalities.
  • Strains of V. parahaemolyticus and V. vulnificus were resuspended and incubated to reactivate for 1 hr at 32°C in TSB culture medium with the inclusion of HQPC at 5%, 10% and 15%. Incubations were carried out immediately in ChromAgar Vibrio to determine the effect on bacteria growth. The results showed that HQPC at 10% inclusion level can strongly affect V. vulnificus growth. Rate with a 72% reduction in bacteria population at 18 hrs. At the 15% inclusion level the growth rate of V. parahaemolyticus is reduced significantly up to 63% (FIG. 21).
  • Example 13 Detection of V. parahaemolyticus bacteria using PCR when exposed to HQPC at inclusion levels of 1% and 2%
  • strain VPQB020 V. parahaemolyticus
  • Bacteria were grown in ChromAgar Vibrio with HQPC inclusion levels of 1% and 2%. CFU were counted in plates and PCR of each of the bacteria that grew in the culture medium was carried out at the different inclusion levels.
  • Table 10 V. parahaemolyticus growth in the presence of HQPC at inclusion levels of 1% and 2%. Bacteria presence was detected using PCR.
  • Example 14 Evaluation of the inhibitory activity of HQPC at inclusion levels of 1% and 2% against three (3) strains of commercial probiotics [00245] Three (3) commercial probiotics were used for this test. The strains were reactivated in TSB culture medium with the inclusion of 1% and 2% HQPC and incubated at 30°C for 24 hrs. Subsequently, samples were incubated every six (6) hrs in TSA medium without salt. The results shown are from CFU readings and bacteria levels counted in the agar plates versus CFU counts obtained from the controls. This ratio was used to find a relationship of HQPC inhibitions vs. probiotic activity. The commercial probiotics show an inhibition of 71%, 38% and 6% with HQPC at 1% and 72%, 44% and 8% with HQPC at 2% (FIG. 23).
  • Example 15 Effects of HQPC on Shrimp at High Stocking Density
  • Pathogen free shrimp were used in this Example (as determined by PCR). Tanks with a capacity of 350 L were used, and all tanks were outfitted with an activated coral filter, aerated and covered with a plastic film cap to reduce the risk of cross contamination. Brackish water with a salinity of 20 parts per thousand (ppt) was used.
  • MWG mean weight gain
  • ADG average daily growth
  • SGR specific growth rates
  • Wi and W2 are the weights at times ti and t2, respectively with ti and t2 are being the first and last day of the feeding period, respectively.
  • N represents the number of shrimp
  • Ni represents the initial number of shrimp
  • N f represents the final number of shrimp.
  • Results are presented as the mean ⁇ standard deviation. Average values of water quality parameters, survival rate, and growth performance parameters were analyzed by the Duncan test with 5% in terms of significance level using statistical analysis of variance (ANOVA) of the SPSS software version 20.
  • the trial indicates that the shrimp growth performance after 61 -day of Diet A administration had significantly better results compared to the other diets in terms of final mean weight (FW), mean weight gain, average daily growth (ADG), specific growth rate (SGR), and feed conversion ratio (FCR).
  • FW final mean weight
  • ADG average daily growth
  • SGR specific growth rate
  • FCR feed conversion ratio
  • this antibacterial property of the HQPC i.e., to inhibit Vibrio capacity, at levels as low as between 1 and 10% inclusion rates in a feed

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Sustainable Development (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
PCT/US2022/015266 2021-02-04 2022-02-04 Use of high quality protein concentrate as an antibacterial for shellfish WO2022225593A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202280026501.XA CN117202791A (zh) 2021-02-04 2022-02-04 高品质蛋白浓缩物作为水生有壳动物抗菌剂的用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163145738P 2021-02-04 2021-02-04
US63/145,738 2021-02-04

Publications (1)

Publication Number Publication Date
WO2022225593A1 true WO2022225593A1 (en) 2022-10-27

Family

ID=83722568

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2022/015266 WO2022225593A1 (en) 2021-02-04 2022-02-04 Use of high quality protein concentrate as an antibacterial for shellfish

Country Status (3)

Country Link
CN (1) CN117202791A (zh)
EC (1) ECSP23066511A (zh)
WO (1) WO2022225593A1 (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107760608A (zh) * 2017-06-08 2018-03-06 中国科学院青岛生物能源与过程研究所 一种高效生产低分子普鲁兰多糖的诱变菌株及其应用
WO2018221716A1 (ja) * 2017-06-02 2018-12-06 国立大学法人東京海洋大学 ＥＭＳ／ＡＨＰＮＤに対する防御効果を提供するＩｇＹ抗体含有餌料
WO2019012460A1 (en) * 2017-07-13 2019-01-17 Plentex Philippines Inc. FERMENTED AGRICULTURAL BIOMASS COMPOSITIONS AND METHODS OF PRODUCTION THEREOF
CN110973348A (zh) * 2019-11-11 2020-04-10 华南农业大学 一种混合菌种发酵豆渣的方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018221716A1 (ja) * 2017-06-02 2018-12-06 国立大学法人東京海洋大学 ＥＭＳ／ＡＨＰＮＤに対する防御効果を提供するＩｇＹ抗体含有餌料
CN107760608A (zh) * 2017-06-08 2018-03-06 中国科学院青岛生物能源与过程研究所 一种高效生产低分子普鲁兰多糖的诱变菌株及其应用
WO2019012460A1 (en) * 2017-07-13 2019-01-17 Plentex Philippines Inc. FERMENTED AGRICULTURAL BIOMASS COMPOSITIONS AND METHODS OF PRODUCTION THEREOF
CN110973348A (zh) * 2019-11-11 2020-04-10 华南农业大学 一种混合菌种发酵豆渣的方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DANGTIP SIRINTIP, SIRIKHARIN RATCHANOK, SANGUANRUT PIYACHAT, THITAMADEE SIRIPONG, SRITUNYALUCKSANA KALLAYA, TAENGCHAIYAPHUM SUPARA: "AP4 method for two-tube nested PCR detection of AHPND isolates of Vibrio parahaemolyticus", AQUACULTURE REPORTS, ELSEVIER BV, NL, vol. 2, 1 November 2015 (2015-11-01), NL , pages 158 - 162, XP093000586, ISSN: 2352-5134, DOI: 10.1016/j.aqrep.2015.10.002 *
DATABASE GENBANK [online] 7 June 2020 (2020-06-07), "Vibrio parahaemolyticus isolate AHPND-PirA-KK-VIET1 PirA (pirA) gene, partial cds", XP093000592, Database accession no. MN 480427.1 *
DATABASE GENBANK [online] 7 June 2020 (2020-06-07), "Vibrio parahaemolyticus isolate AHPND-PirB-KK-VIET1 PirB (pirB) gene, partial cds", XP093000590, Database accession no. MN 480428.1 *
KIM: "Effect of Fermented Soybean Meal by Bacillus subtilis in Pacific White Shrimp Liopenaeus vannamei Diets on Growth Performance, Innate Immunity and Disease Resistance", KOREAN JOURNAL OF FISHERIES AND AQUATIC SCIENCES, vol. 50, no. 1, 16 February 2017 (2017-02-16), XP093000584, DOI: 10.5657/KFAS.2017.0008 *

Also Published As

Publication number Publication date
ECSP23066511A (es) 2023-10-31
CN117202791A (zh) 2023-12-08

Similar Documents

Publication Publication Date Title
US11896031B2 (en) Microbial-based process for high quality protein concentrate
Kroeckel et al. When a turbot catches a fly: Evaluation of a pre-pupae meal of the Black Soldier Fly (Hermetia illucens) as fish meal substitute—Growth performance and chitin degradation in juvenile turbot (Psetta maxima)
US20160242435A1 (en) High quality protein concentrate from canola meal
US20210137135A1 (en) Microbial-based process for improved quality protein concentrate
AU2021287209A1 (en) Microbial-based process for improved quality protein concentrate
US20220132885A1 (en) Microbial-based process for quality protein concentrate from hempseed
US20220218770A1 (en) Use of high quality protein concentrate as an antibacterial for shellfish
WO2022225593A1 (en) Use of high quality protein concentrate as an antibacterial for shellfish
US11800882B2 (en) Microbial-based process for high quality protein concentrate
US11992028B2 (en) Microbial-based process for high quality protein concentrate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22792151

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 202280026501.X

Country of ref document: CN

122 Ep: pct application non-entry in european phase

Ref document number: 22792151

Country of ref document: EP

Kind code of ref document: A1